Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Sanofi-Aventis Ireland Limited regarding Valproate (Epilim) – ongoing review of potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the three months prior to conception.
Important Safety Information – Valproate (Epilim)